What to expect from Actavis-Allergan merger: CEO By: CNBC.com News February 18, 2015 at 08:46 AM EST Actavis announced it will take the name Allergan after a deal to purchase the company closes. CEO Brent Saunders discussed the company's future with CNBC. Read More >> Related Stocks: Actavis Plc Thomson Reuters Corporation